Evidence-based value and access strategies

Case Study: Competitive Intelligence


Return to Clinical & Market Access Intelligence


A large pharma company engaged Compass to conduct a strategic assessment of the metabolic profiles of the company and its competitors

Situation:
Client requested strategies to take advantage of opportunities and address potential gaps over the next 10 years in the metabolic space

Key Objective:
Characterize management of metabolic portfolios among ten key pharmaceutical companies with R&D programs in discovery and development of new agents and / or delivery systems to treat metabolic disorders

Methodology:

  • Primary research through telephone interview of US and EU KOLs (n=7), external commercial / R&D / BD executives (n=32) and client commercial / R&D executives for an assessment of the competitive situation, identification of attributes leading to long term success, and rating of portfolios
  • Primary research through an online survey of 14 business development external execs to prioritize attributes and rate companies

Results:

  • Ranking of metabolic companies and key strengths and weakness of client
  • Identification of competitors that will challenge client’s portfolio
Sample Deliverable
Top attributes selected by respondents were used to rank the metabolic companies

CS_Compet_Intell